April showers bring more biotechs to Nasdaq, as Rain and Impel bump 2021's total raise above $6B
Editor’s note: Interested in following biopharma’s fast-paced IPO market? You can bookmark our IPO Tracker here.
What’s that in the sky — is it a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
